| 9541 |
1 |
Women and Cardiovascular Health: Lessons Learned from COVID-19 |
| 9542 |
1 |
The Impact of Screening & Prevention on Cardiovascular Disease in Women |
| 9543 |
1 |
Sex Specific Pathways from Arrhythmias, Valves, and Heart Failure to Vascular Disease |
| 9544 |
1 |
The Heart in Rheumatic, Autoimmune and Inflammatory Diseases in Women |
| 9545 |
1 |
Tobacco Product Use and COVID-19: An Overview of the Science and Public Health Implications |
| 9552 |
1 |
AffloVest |
| 9553 |
1 |
COVID-19: Nasal High Flow Therapy in COVID-19 Respiratory Illness |
| 9554 |
0.5 |
Chronic Rhinosinusitis with Nasal Polyps: Medical and SurgicalManagement |
| 9555 |
1.0 |
Practical Consiferations for the Asthma Quality Standards |
| 9556 |
1.0 |
To Air is Human :To Wheeze Divine: Asthma Therapy 2021 |
| 9557 |
0.75 |
Immunology and Management of Severe Asthma |
| 9558 |
1.0 |
Unboxing IQOS: History, risk perceptions, and clinical implications |
| 9559 |
1.0 |
Pulmonary Rehabilitation Moving Toward our New Normal |
| 9560 |
1.0 |
An overview of the newly published 2020 GOLD Science Committee Report |
| 9561 |
2 |
Trauma Assessment and Treatment |
| 9562 |
1.0 |
Pulmonary Hyptertension: What Every Respiratory Healthcare Providers Should Know. |
| 9563 |
1 |
Covid - 19 and COPD |
| 9565 |
1 |
Communicable / Infectius Disease |
| 9566 |
0.5 |
Immunological Emergency |
| 9567 |
1 |
Trauma Triage |
| 9568 |
1 |
PEDIATRIC CARDIAC ARREST |
| 9569 |
1 |
High Flow Heat and Humidity in COPD : Use in hospital and beyond |
| 9570 |
.5 |
OB Emergencies |
| 9574 |
1.5 |
Inpatient COPD Care: Reducing Cost, Improving Quality, and Reducing Readmissions |
| 9575 |
1 |
Vaping as cause of lung injury |
| 9576 |
1.5 |
The 5 Rights of End of Life Care |
| 9577 |
2.0 |
Fundamental Concepts & Use of Neonatal/Pediatric High Flow Nasal Cannula and Nasal Continuous Positive Airway Pressure |
| 9578 |
1 |
Viral Respiratory Pandemics: Lessons Learned |
| 9579 |
7 |
Avoiding Infant Lung Injury Conference |
ND State Board of